Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Datasets
Projects
Search by expertise, name or affiliation
Network pharmacology for mechanistically redefined comorbidities
Mahmoud (Hassan Mahmoud) Elbatrik
Pharmacology and Personalised Medicine
Carim - Vessels
MHeNs - Neuroscience
Research output
:
Thesis
›
Doctoral Thesis
›
Internal
343
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Network pharmacology for mechanistically redefined comorbidities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Comorbidity
100%
Hypertension
100%
Network Pharmacology
100%
Signaling Modules
100%
NADPH Oxidase 5
100%
Complex Disease
50%
Diabetes
50%
Molecular Mechanism
50%
Age-related
50%
Signaling Network
50%
Current Therapies
50%
Knock-in Mouse Model
50%
Pathomechanism
50%
Hypertensive Patients
50%
Leading Causes of Death
50%
Multi-target
50%
NO Synthase
50%
Causal Mechanisms
50%
Reactive Oxygen Species Signaling
50%
CGMP Signaling
50%
Target-based Approach
50%
Diseasome
50%
Network Medicine
50%
Network Modules
50%
Comorbidites
50%
Symptomatic Therapy
50%
INIS
therapy
100%
hypertension
100%
symptoms
100%
oxidases
100%
pharmacology
100%
diseases
50%
patients
50%
death
50%
mice
50%
oxygen
50%
organs
50%
medicine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Network Pharmacology
100%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 5
100%
Comorbidity
100%
Disease
50%
Nitric Oxide Synthase
50%
Reactive Oxygen Metabolite
50%
Cerebrovascular Accident
50%
Biochemistry, Genetics and Molecular Biology
NAD(P)H Oxidase
100%
Comorbidity
100%
Nitric Oxide Synthase
50%